✅ Model Answer:
• Contrast reflux from the bladder into the ureters and renal pelves (bilateral).
• Moderate ureteral dilation.
• Blunting of the calyceal fornices.
•
• Diagnosis: Bilateral Vesicoureteral Reflux (VUR) – Grade IV (International Reflux Study classification).

✅ Model Answer:
• Grade I: Reflux into the ureter only – no dilation.
• Grade II: Reflux into the ureter and pelvicalyceal system – no dilation, normal calyces.
• Grade III: Mild to moderate dilation of the ureter and pelvicalyceal system – blunting of the calyceal fornices.
• Grade IV: Moderate to gross dilation of the ureter – moderate dilation of the pelvicalyceal system with loss of papillary impressions.
• Grade V: Massive dilation and tortuosity of the ureter – marked dilation of the pelvicalyceal system with loss of papillary impressions and intrarenal reflux.

✅ Model Answer:
• Primary VUR: Congenital shortening or absence of the submucosal ureteral tunnel → incompetent ureterovesical junction.
• Flap-valve mechanism: Normally, the intramural ureter is compressed by detrusor contraction during bladder filling, preventing reflux. In VUR, the tunnel is too short, so the valve is incompetent.
• In children, the ureteral tunnel length is measured as the ratio of tunnel length to ureteral diameter (normal >5:1).
• Secondary VUR: Due to elevated bladder pressure (posterior urethral valves, neurogenic bladder, voiding dysfunction, constipation).

✅ Model Answer:
• First febrile UTI in children <2 years – to detect VUR.
• Recurrent febrile UTIs – to assess for VUR.
• Abnormal renal ultrasound – hydronephrosis, ureteral dilation, renal scarring.
• Suspected posterior urethral valves – in male neonates with urinary obstruction.
• Voiding dysfunction or neurogenic bladder – to evaluate bladder and urethral anatomy.
• Pre- and post-operative evaluation – after endoscopic injection or ureteral reimplantation.
• Siblings of children with VUR – high risk (up to 30%).

✅ Model Answer:
• Continuous antibiotic prophylaxis (CAP) is recommended for:
- Infants and young children with Grade III-V VUR.
- Children with recurrent febrile UTIs despite conservative measures.
- Children with renal scarring or dilated VUR.
• Prophylactic agents:
- Trimethoprim-sulfamethoxazole (TMP-SMX) – 2 mg/kg/day (trimethoprim component).
- Nitrofurantoin – 1-2 mg/kg/day (but not in neonates).
- Amoxicillin – for infants <2 months.
• Duration: Until VUR resolves or until toilet training is complete.

✅ Model Answer:
• BBD is a major contributing factor to VUR (especially in older children).
• Constipation: Distended rectum compresses the bladder, increasing intravesical pressure and promoting reflux.
• Voiding dysfunction: Dysfunctional voiding (holding urine, straining) leads to elevated bladder pressures and secondary VUR.
• Management: Treat constipation (stool softeners, dietary changes, toilet training).
• Resolution: Treating BBD can lead to spontaneous resolution of VUR in up to 50% of cases.

✅ Model Answer:
• Breakthrough febrile UTIs despite antibiotic prophylaxis.
• Grade IV-V VUR with renal scarring or renal growth impairment.
• Failed spontaneous resolution (typically after 4-6 years of age).
• Poor compliance with antibiotic prophylaxis.
• Associated anomalies – duplex collecting system, ureterocele, posterior urethral valves.
• Surgical options:
- Endoscopic injection (Deflux) – bulking agent at the ureteral orifice.
- Ureteral reimplantation (open or laparoscopic) – creates a longer submucosal tunnel.

✅ Model Answer:
• Spontaneous resolution rates:
- Grade I: ~80% by age 5.
- Grade II: ~70% by age 5.
- Grade III: ~50% by age 6.
- Grade IV: ~30% by age 6.
- Grade V: <10% spontaneous resolution.
• Resolution is more likely if:
- VUR is unilateral.
- The child is younger at diagnosis.
- There is no renal scarring.
- Bladder and bowel function are normal.
• Spontaneous resolution typically occurs by age 5-6 years as the ureteral tunnel grows.

✅ Model Answer:
• Renal scarring (reflux nephropathy) is a major complication of VUR.
• Mechanism: Intrarenal reflux → infection → inflammatory damage → scar formation.
• Risk factors: High-grade VUR (Grade IV-V), young age, recurrent febrile UTIs, delayed diagnosis.
• Imaging: DMSA scan is the gold standard for detecting renal scars.
• Consequences: Hypertension, proteinuria, chronic kidney disease, end-stage renal disease.
• Management: Prevent UTIs, monitor blood pressure, renal function.

✅ Model Answer:
• This child has bladder and bowel dysfunction (BBD) contributing to VUR.
• Management:
1. Treat constipation: Polyethylene glycol (PEG) 0.5-1 g/kg/day, dietary modifications (increase fluids, fiber).
2. Toilet training – scheduled voiding every 2-3 hours.
3. Antibiotic prophylaxis: TMP-SMX (if febrile UTIs are recurrent).
4. Monitor: Repeat VCUG in 12-18 months.
5. If constipation and voiding improve: VUR may resolve spontaneously without surgery.

✅ Model Answer:
• DMSA (dimercaptosuccinic acid) scan is a functional renal imaging study.
• Role:
- Detects renal scarring (reflux nephropathy) – focal areas of reduced tracer uptake.
- Assesses differential renal function – split function (normal >45%).
- Indications: High-grade VUR, recurrent UTIs, abnormal renal ultrasound.
- Timing: Preferably performed 4-6 months after a UTI (to avoid acute inflammation).
- Key point: Scarring indicates irreversible renal damage and guides management.

✅ Model Answer:
• This is a breakthrough infection – an indication for surgical intervention.
• Next steps:
1. Treat the acute UTI – culture, appropriate antibiotics (IV if septic).
2. Refer to pediatric urology – for consideration of definitive treatment.
3. Surgical options:
- Endoscopic injection (Deflux) – if the anatomy is suitable.
- Ureteral reimplantation – if endoscopic therapy fails or for Grade V VUR.
4. DMSA scan – to assess for new renal scarring.